91ÁÔÆæ Press journal overviews
The 91ÁÔÆæ Journal
For high-quality, full-length papers and expert reviews relevant to the molecular, cellular and biochemical life sciences.
Editor-in-Chief: Seamus Martin
Key Features: Diverse and engaging | Most accepted manuscripts undergo only one round of revision | Free to publish (no page charges) or choose options
Key Metrics 2024: Impact Factor 4.2 | CiteScore 13.1 | Cited Half-life 7.5 years | Median time from submission to first decision after peer review: 47 days
91ÁÔÆæ Letters
For rapid publication of research reports that significantly impact and advance knowledge, and timely reviews of wide interest in the molecular biosciences.
Editor-in-Chief: Michael Brunner
Key Features: primary research and review article formats ´¥Ìý builds bridges between science and society | Free to publish (no page charges) or choose options
Key Metrics 2024: Impact Factor 3.0 | CiteScore 6.1 | Cited Half-life 18.0 years | Median time from submission to first decision after peer review: 28 days
 on Bluesky
 on X
91ÁÔÆæ Open Bio
For publication of research articles in the molecular and cellular life sciences, with emphasis on technical and ethical quality rather than objective judgements of significance.
Editor-in-Chief: Miguel De la Rosa
Key Features: Diverse article formats, including | option ´¥Ìý free to publish ´¥Ìý with the annual 91ÁÔÆæ Congress ´¥Ìý
Key Metrics 2024: Impact Factor 2.3 | CiteScore 5.5 | Cited Half-life 4.5 years | Median time from submission to first decision after peer review: 36 days
Award: Â is awarded to an early career researcher who has published an outstanding paper in the previous calendar year.
Molecular Oncology
For publishing high-impact research articles in basic, translational and clinical cancer research, as well as reviews and policy papers discussing emerging concepts in cancer research, cancer diagnosis, prevention and care.
Editor-in-Chief: Kevin Ryan
Key Features: Diverse article formats, including Ìý´¥Ìý option | Affiliate journal of the and the ´¥ÌýÌý´¥
Key Metrics 2024: Impact Factor 4.5 | CiteScore 11.4 | Cited Half-life 5.0 years | Median time from submission to first decision after peer review: 47 days
Prizes: For outstanding  at key meetings, and top entries of the annual writing competition launched on World Cancer Day.